New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc.
Industry: Life Sciences ・ $AMLX on Nasdaq ・ Market Cap: Small
New Purchase Insider
CEO Sales
Top Executive Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 4 / 6 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 3 / 5 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 159,000 / 30,503 39,750 / 5,084 |
| VALUE PURCHASED/SOLD Transaction Average | $395,830 / $353,936 $98,958 / $58,989 |
| PURCHASE RANGE | $9,450 - $220,000 |
| SALE RANGE | $19,655.4 - $95,383.53 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
1 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
2 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
100%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.355 0.2 |
VALUE GINI INDEX Sector Average | 0.398 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
38.3%
DIRECTORS
61.7%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.171 0.295 |
VALUE GINI INDEX Sector Average | 0.317 0.288 |
Amylyx Pharmaceuticals, Inc. 1Y Trade Transactions